Most compounding facilities simply cannot verify peptide identity through mass spectrometry, quantify impurities as a result of HPLC, or evaluate endotoxin stages precisely. Some compounding pharmacies market retatrutide availability by telehealth prescriptions. These promises violate federal regulation. Knowledge the authorized framework govern